Unknown

Dataset Information

0

Low-dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma.

ABSTRACT:

SUBMITTER: Chen YP 

PROVIDER: S-EPMC9558682 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Low-dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma.

Chen Yu-Pei YP   Shen Jia-Yi JY   Deng Zhen-Ji ZJ   Sun Ying Y   Liang Xiao-Yu XY   Lv Jia-Wei JW   Ma Jun J  

Cancer communications (London, England) 20220804 10

Similar Datasets

Unknown Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
| S-EPMC9513587 | biostudies-literature
Unknown Synergy Between Low Dose Metronomic Chemotherapy and the pH-centered Approach Against Cancer.
| S-EPMC6862380 | biostudies-literature
Unknown Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy.
| S-EPMC5834779 | biostudies-literature
Unknown Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy.
| S-EPMC7795790 | biostudies-literature
Unknown Cost-effectiveness analysis of the combination of low-dose nivolumab with triple metronomic chemotherapy for advanced head and neck squamous cell carcinoma in China.
| S-EPMC12433840 | biostudies-literature
Unknown Anti-tumor effects of low-dose metronomic vinorelbine in combination with alpelisib in breast cancer cells.
| S-EPMC10043427 | biostudies-literature
Unknown Ultra-high dose-rate proton FLASH improves tumor control.
| S-EPMC10527231 | biostudies-literature
Unknown Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer.
| S-EPMC4278254 | biostudies-literature
Unknown A tumor microenvironment-associated circRNA predictor for tumor relapse and chemotherapy vulnerability in nasopharyngeal carcinoma.
| S-EPMC10711393 | biostudies-literature
Unknown Metronomic chemotherapy offsets HIFα induction upon maximum-tolerated dose in metastatic cancers.
| S-EPMC7507002 | biostudies-literature